|
chemicals and pharmaceuticals
This page provides some benchmarks for acquisitions and
disposals during the telecommunication booms and busts
of the past twenty years.
It covers -
pharmaceuticals
Major drug companies have been claimed as casualties of
their own success, creating 'blockbuster' pharmaceuticals
in high demand around the world but then facing competition
from generic treatments and thus needing a rapid replacement
of new drugs to fill marketing pipelines. Absorbing a
large competitor offers one means of quickly obtaining
a substitute blockbuster and economies of scale for new
R&D, although critics argue that much innovation is
not coming from the big labs.
Pharmaceutical sector landmarks include -
- Novartis
pays US$5.1bn to take full control of Chiron in 2005
- Botox
maker Allergan agrees to acquire rival Inamed for US$3.2bn
in 2005
-
Amgen agrees to acquire Abgenix for US$2.2bn in 2005
- Fujisawa
Pharmaceutical merges with merger with Yamanouchi in
US$7.6bn deal in 2005 to create Astellas
- Sankyo
joins with Daiichi Pharmaceutical in US$7.7bn merger
in 2005
-
Sanofi-Synthelabo buys Aventis for US$66.2bn in 2004
- Bayer
buys Roche OTC business for US$2.96bn in 2004
- UCB
buys Celltech for US$2.7bn in 2004
-
Pfizer acquires Pharmacia for US$60bn in 2003
- Shire
Pharmaceuticals Group acquires BioChem Pharma in all-stock
deal worth C$5.9bn in 2003
-
Amgen buys Immunex for US$16.7bn in 2002
- Du
Pont sells pharmaceutical operations to Bristol-Myers
Squibb for US$7.5bn in 2001
- Glaxo
merges with SmithKline in US$172bn deal in 2000
-
Pfizer acquires Warner-Lambert for US$88bn in 2000
- Astra
merges with Zeneca as AstraZeneca in US$34bn deal in
1999
- Ciba-Geigy
merges with Sandoz as Novartis in US$63bn deal in 1996
- Dow
sells pharmaceutical operations to Hoechst for US$7.1bn
in 1994
- Monsanto
buys Kelco from Merck for US$1bn in 1993
Landmarks
prior to the 1990s include -
- Beecham
acquires SmithKline Beckman for US$8.9bn in 1989
-
Bristol-Myers acquires Squibb for US$11.9bn in 1989
- Dow
buys Marion Laboratories in 1989
- Monsanto
buys GD Searle for US$2.5bn in 1985
- Dow
buys Merrill Drug arm of Richardson-Vicks for US$260m
in 1981
medical devices
Landmarks in the medical device sector include -
-
Angiotech Pharmaceuticals agrees to acquire
American Medical Instruments Holdings for US$785m in
2006
- Boston
Scientific pays US$27bn for Guidant in 2006
- Smith
& Nephew and Beiersdorf sell bandage-maker BSN Medical
GmbH for €1.03bn in 2005
chemicals
Chemical industry landmarks include -
-
Macquarie Bank consortium buys buying Dyno Nobel Holding
ASA for US$1.7bn in 2005
- Blackstone
buys Celanese for US$3.8bn in 2004
- Dow
Chemical buys Union Carbide for US$9.3bn in 2001
- Degussa-Hüls
pays £1.36bn for Laporte in 2000
-
AstraZeneca sells Zeneca Specialities to Cinven for
£1.25bn in 1999
- DuPont
pays US$7.7bn for Pioneer Hi-Bred in 1999
- ICI
sold its remaining industrial chemicals businesses to
Ineos for £325m in 2000
- ICI
sells aromatics and Tioxide Group to Huntsman for £1.7bn
in 1999
-
Suez Lyonnaise des Eaux buys Nalco Chemical for US$4.1bn
in 1999
- Hoechst
sells its 45% holding in Clariant for €2.8bn in
1999
- Du
Pont sells 30% of Conoco in IPO for US$4.4bn in 1998
-
Akzo Nobel pays £1.8bn for Courtaulds in 1998
- Ciba
Speciality Chemicals pays £1.42bn for Allied Colloids
in 1998
- ICI
sells polyester businesses to DuPont for US$3bn in 1997
-
Unilever sells speciality chemicals businesses (Crosfields,
Unichema etc) to ICI for £4.9bn in 1997
- Monsanto
sells plastics arm to Bayer for US$5.8bn in 1996
Landmarks
prior to the 1990s include
- ICI
acquires Stauffer Chemical in 1987
- Union
Carbide sells Ever Ready to Ralston Purina for US$1.4bn
in 1986
- Du
Pont spins off PVC operations as US$600m Vista Chemical
in 1984
- Du
Pont buys Conoco in 1981
- Dow
sells oil & gas operations to Apache Petroleum and
Dome for US$490m in 1982
- Ciba
and Geigy merge as Ciba-Geigy in 1970
- Du
Pont buys Roessler & Haaslacher in 1930
- Du
Pont buys Gracelli Chemical in 1928
- Imperial
Chemical Industries formed through merger of Brunner
Mond, Nobel Industries, British Dyestuffs and United
Alkali in 1926
- IG
Farben Industrie formed through mergers in Germany
studies
For a panoramic view of recent developments and drivers
see Alfred Chandler's Shaping the Industrial Century:
The Remarkable Story of the Evolution of the Modern Chemical
and Pharmaceutical Industries (Cambridge: Harvard
Uni Press 2005).
next page (metals
and mining)
|